Showing 581 - 600 results of 16,418 for search '"Therapy"', query time: 0.07s Refine Results
  1. 581
  2. 582

    An Update on the Potential of Mesenchymal Stem Cell Therapy for Cutaneous Diseases by Yanyun Li, Ziyu Ye, Weiqin Yang, Qunzhou Zhang, Jincheng Zeng

    Published 2021-01-01
    “…Therefore, understanding the biological and immunological characteristics of MSCs is important to standardize and optimize MSC-based regenerative therapy. In this review, we highlight the mechanisms underlying MSC-mediated immunomodulation and tissue repair/regeneration and present the latest development of MSC-based clinical trials on cutaneous diseases.…”
    Get full text
    Article
  3. 583

    Incomplete Resolution of Deep Vein Thromboses during Rivaroxaban Therapy by Jonathan M. Yaghoubian, Jacob Adashek, Bahareh Yaghoubian-Yazi, Menachem Nagar, Nojan Toomari, Richard J. Pietras, Uri M. Ben-Zur

    Published 2017-01-01
    “…We present the case of a patient with a deep vein thrombosis (DVT) who failed rivaroxaban therapy. Our patient initially presented with left lower extremity edema, erythema, and pain. …”
    Get full text
    Article
  4. 584
  5. 585
  6. 586

    Characterization of home oxygen therapy prescription. Cienfuegos Municipality, 2022 by Aracelia Esther Valdés Zamora, Idaimy Molina del Sol, Anay de la C. Núñez Herrera, Noel A. Pardillo Mustelier, Anisbelys Álvarez

    Published 2024-03-01
    “…<p><strong>Foundation</strong>: oxygen therapy, indicated with the intention of treating or preventing hypoxia manifestations, has shown to increase survival in patients with chronic obstructive pulmonary disease and respiratory failure. …”
    Get full text
    Article
  7. 587

    TNF-α Dysregulation in Asthma: Relationship to Ongoing Corticosteroid Therapy by Susan Waserman, Jerry Dolovich, Mary Conway, Jean S Marshall

    Published 2000-01-01
    “…However, alterations in systemic regulation of this cytokine in asthma have not been examined in the context of corticosteroid therapy.…”
    Get full text
    Article
  8. 588
  9. 589

    Outcomes of Neonatal Candidiasis: The Impact of Delayed Initiation of Antifungal Therapy by Heather Cahan, Jaime G. Deville

    Published 2011-01-01
    “…Delayed institution of antifungal therapy was associated with increased mortality. In addition, length of hospitalization, duration of prior antibacterial therapy, mechanical ventilation, and CVC use, as well as evidence of end-organ disease, were associated with an adverse outcome. …”
    Get full text
    Article
  10. 590

    Difficult-to-Treat or Resistant Hypertension: Etiology, Pathophysiology, and Innovative Therapies by Vasilios Papademetriou, Costas Tsioufis, Alan Gradman, Henry Punzi

    Published 2011-01-01
    “…This special issue of the journal expoars a whole spectrum of topics related to resistant hypertension: several articles address pathophysiolog and secondary causes of resistant hypertension and modern approaches to therapy. Of interest is the referance to the newer interventional approaches, that is, Baroreceptor stimulation therapy and catheter based sympathetic renal denervation.…”
    Get full text
    Article
  11. 591

    Role of Interleukin- (IL-) 17 in the Pathogenesis and Targeted Therapies in Spondyloarthropathies by I-Tsu Chyuan, Ji-Yih Chen

    Published 2018-01-01
    “…Recently, several clinical trials targeting IL-17 pathways demonstrated the positive response of IL-17 blockade in treating AS, indicating a great potential of IL-17-targeting therapy in SpA. In this review article, we have discussed the contributing role of IL-17 and different IL-17-producing cells in the pathogenesis of SpA and provided an outline of therapeutic application of the IL-17 blockade in the treatment of SpA. …”
    Get full text
    Article
  12. 592

    Sclerostin Antibody Therapy for the Treatment of Osteoporosis: Clinical Prospects and Challenges by Claire MacNabb, D. Patton, J. S. Hayes

    Published 2016-01-01
    “…In anticipation of phase III trial results which may potentially signify a significant step in achieving market approval here, we review the preclinical and clinical emergence of sclerostin antibody therapies for both osteoporosis and alternative applications. …”
    Get full text
    Article
  13. 593
  14. 594

    Adjuntive nicergoline therapy for severe persistent corneal epithelial defects. by Valeria Oliva-Biénzobas, Enrique O. Graue-Hernandez, Guillermo Raul Vera-Duarte, Jesus Cabral-Macías, Juan Serna-Ojeda, Victor Boullosa, Arturo Ramirez-Miranda, Vishal Jhanji, Victor L. Perez, Alejandro Navas

    Published 2025-04-01
    “…Results: Two male and seven female patients with persistent corneal epithelial defects unresponsive to conventional therapy treated with oral nicergoline were included. …”
    Get full text
    Article
  15. 595

    Pulse Dye Laser Therapy Successful for Elastosis Perforans Serpiginosa by Giulia Rinaldi, Alisha Chacko, Samira Batul Syed

    Published 2019-01-01
    “…Our results show that pulse dye laser therapy is a safe and effective treatment for elastosis perforans serpiginosa.…”
    Get full text
    Article
  16. 596

    RANKL-Targeted Therapies: The Next Frontier in the Treatment of Male Osteoporosis by Alicia K. Morgans, Matthew R. Smith

    Published 2011-01-01
    “…Men treated with androgen deprivation therapy experience a decline in bone mineral density and have an increased rate of fracture. …”
    Get full text
    Article
  17. 597
  18. 598

    Efek Pemakaian Hormone Replacement Therapy (HRT): Systematic Review by Biomechy Oktomalio Putri, Noverial Noverial

    Published 2023-07-01
    “…One effort to reduce this risk is to use Hormone Replacement Therapy (HRT). Objective: To analyzed  the effect of HRT use on postmenopausal women.Methods: This research was a systematic review by searching articles in the PubMed electronic journal with keywords used [“Premenopausal women” OR “Postmenopausal women”, OR “Menopause”] AND  [“Hormone Replacement Therapy” OR “Menopausal Hormone Therapy”] AND [“Increased risk disease” OR “Decreased risk disease”]. …”
    Get full text
    Article
  19. 599

    Curcumin as a Supportive Therapy in Type 2 Diabetic Patients by Anand Seth, Sravya Iyyuni, Saurabh Sharma, Ritu Sethi, Suresh Nath, Michael Imeokparia

    Published 2024-01-01
    “…In the treatment of T2DM, curcumin has demonstrated much potential as an adjunct therapy due to its anti-inflammatory properties and its ability to reduce oxidative stresses within the body. …”
    Get full text
    Article
  20. 600

    Profile of paediatric occupational therapy practice in Eastern Mediterranean countries by Zainab A. Jasem

    Published 2024-12-01
    “…Scandinavian Journal of Occupational Therapy…”
    Get full text
    Article